Literature DB >> 17176584

ICD-9 codes for identifying influenza hospitalizations in children.

Ron Keren, Anna Wheeler, Susan E Coffin, Theoklis Zaoutis, Richard Hodinka, Kateri Heydon.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 17176584      PMCID: PMC3290931          DOI: 10.3201/eid1210.051525

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: The effect of influenza on young children is substantial, but most infections are clinically unrecognized (). As a result, without routine laboratory confirmation of influenza infection in patients admitted to the hospital with influenzalike illness, accurate estimates of influenza-related hospitalization rates are difficult to obtain. Several statistical models have been developed to generate estimates of excess or influenza attributable hospitalizations, all of which calculate the rate of hospitalization above baseline during periods in which influenza is circulating (–). However, their accuracy is limited when viruses such as respiratory syncytial virus (RSV) and parainfluenza are cocirculating with influenza. International Classification of Diseases 9th revision (ICD-9) diagnostic codes specific to influenza (487.0, 487.1, and 487.8) are easily retrieved from hospital discharge records. However, researchers and public health officials have rarely used them for influenza hospitalization surveillance, presumably because they lack sensitivity for identifying true influenza infections, although this assumption has never been tested. To determine the sensitivity and positive predictive value of influenza-specific ICD-9 admission or discharge codes (487.0, 487.1, and 487.8), we conducted a retrospective cohort study of all patients <21 years of age hospitalized at the Children's Hospital of Philadelphia with laboratory-confirmed influenza during 3 consecutive influenza seasons (July 2001 through June 2004) (). We compared admission and discharge ICD-9 codes with influenza laboratory results. All specimens were initially tested by rapid solid-phase immunoassay for RSV (Binax; Portland, ME, USA) and influenza (Binax). Direct fluorescent antibody testing for adenovirus, influenza A and B, parainfluenza virus types 1, 2, and 3, and RSV was performed on specimens negative by solid-phase immunoassay for RSV or influenza. Comprehensive viral culture was established for all specimens negative for respiratory viruses by direct fluorescent antibody test. Of 715 cases of laboratory-confirmed influenza identified (Table), 617 (86%) were identified by rapid testing and 98 (14%) by viral culture after rapid test results were negative. A total of 529 patients had influenza-specific admission or discharge ICD-9 codes. The sensitivity of influenza-specific ICD-9 codes was 65% (95% confidence interval [CI] 61%–68%), and the positive predictive value was 88% (95% CI 84%–90%) (Table). Of 66 patients who had influenza-specific admission or discharge ICD-9 codes but negative influenza laboratory results, laboratory tests confirmed parainfluenza (n = 42), Haemophilus influenzae (n = 6; 1 with a positive blood culture and 5 with positive respiratory cultures), H. parainfluenzae (n = 1 wound infection), adenovirus (n = 1), and RSV (n = 2) infections. For 5 patients, influenza infection was documented in their charts, but they had either negative influenza test results or no influenza test performed. Seven patients had the expression "follow-up" written as "f/u" in the assessment section of their admission note, which may have been interpreted by medical coders as flu. We could not determine the reason for miscoding in 2 patients.
Table

Influenza-specific admission or discharge ICD-9 codes (487.0, 487.1, and 487.8.) compared with influenza laboratory test results*

ParameterLCINo LCITotal
Influenza-specific diagnosis codes46366529
No influenza-specific diagnosis codes252
Total715

*ICD-9, International Classification of Diseases-9; LCI, laboratory-confirmed influenza. The sensitivity and positive predictive value of influenza-specific diagnosis codes were 65% and 88%, respectively.

*ICD-9, International Classification of Diseases-9; LCI, laboratory-confirmed influenza. The sensitivity and positive predictive value of influenza-specific diagnosis codes were 65% and 88%, respectively. The sensitivity of influenza-specific diagnosis codes was related to the method of laboratory confirmation. Seventy-three percent (452/617) of patients (95% CI 70%–77%) who had positive rapid test results had influenza-specific admission or discharge diagnosis codes, whereas only 11% (11/98) (95% CI 6%–19%) who had positive influenza viral cultures (and negative rapid test results) had influenza-specific diagnosis codes. Our results have a few policy implications. First, they suggest that in hospitals where routine influenza viral testing is performed, use of admission and discharge ICD-9 codes from hospital billing data for surveillance purposes will systematically underestimate actual influenza-related hospitalizations by 35%. The higher sensitivity of influenza-specific ICD-9 codes in patients with positive rapid test results compared with positive culture results suggests that unlike viral culture results, which generally are not available before discharge, rapid test results are often used to assign influenza-specific ICD-9 codes. Thus, rapid diagnostic tests that are more sensitive (e.g., PCR-based assays) may increase the sensitivity of influenza-specific ICD-9 codes in hospitals that routinely evaluate children admitted with respiratory symptoms of unclear cause. However, the imperfect specificity (94%–98%) of rapid influenza tests will produce a small but not negligible number of false-positive results. In hospitals where influenza testing is not commonly performed, the sensitivity of influenza-specific ICD-9 codes is likely to be lower. Second, the high positive predictive value of influenza-specific ICD-9 codes observed in this study suggests that in hospitals where influenza testing is routinely performed, most patients whose hospitalization summary includes an influenza-specific ICD-9 code actually have influenza. However, misclassification of patients with parainfluenza and H. influenzae infections as patients with influenza demonstrates the potential for systematic coding errors even when influenza testing is routine. Epidemiologists and public health officials should be aware that influenza-specific ICD-9 codes assigned in a setting of routine rapid diagnostic testing may be useful for following trends. However, these codes will substantially underestimate the actual number of influenza-related hospitalizations.
  9 in total

1.  Observations on excess mortality associated with epidemic influenza.

Authors:  T C EICKHOFF; I L SHERMAN; R E SERFLING
Journal:  JAMA       Date:  1961-06-03       Impact factor: 56.272

2.  Influenza and the rates of hospitalization for respiratory disease among infants and young children.

Authors:  H S Izurieta; W W Thompson; P Kramarz; D K Shay; R L Davis; F DeStefano; S Black; H Shinefield; K Fukuda
Journal:  N Engl J Med       Date:  2000-01-27       Impact factor: 91.245

3.  The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.

Authors:  K M Neuzil; B G Mellen; P F Wright; E F Mitchel; M R Griffin
Journal:  N Engl J Med       Date:  2000-01-27       Impact factor: 91.245

4.  Winter viruses: influenza- and respiratory syncytial virus-related morbidity in chronic lung disease.

Authors:  Marie R Griffin; Christopher S Coffey; Kathleen M Neuzil; Edward F Mitchel; Peter F Wright; Kathryn M Edwards
Journal:  Arch Intern Med       Date:  2002-06-10

5.  The underrecognized burden of influenza in young children.

Authors:  Katherine A Poehling; Kathryn M Edwards; Geoffrey A Weinberg; Peter Szilagyi; Mary Allen Staat; Marika K Iwane; Carolyn B Bridges; Carlos G Grijalva; Yuwei Zhu; David I Bernstein; Guillermo Herrera; Dean Erdman; Caroline B Hall; Ranee Seither; Marie R Griffin
Journal:  N Engl J Med       Date:  2006-07-06       Impact factor: 91.245

6.  Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection.

Authors:  Ron Keren; Theoklis E Zaoutis; Carolyn B Bridges; Guillermo Herrera; Barbara M Watson; Anna B Wheeler; Daniel J Licht; Xian Qun Luan; Susan E Coffin
Journal:  JAMA       Date:  2005-11-02       Impact factor: 56.272

7.  Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome.

Authors:  J C Lin; K L Nichol
Journal:  Arch Intern Med       Date:  2001-02-12

8.  Incidence of outpatient visits and hospitalizations related to influenza in infants and young children.

Authors:  Megan A O'Brien; Timothy M Uyeki; David K Shay; William W Thompson; Ken Kleinman; Alexander McAdam; Xian-Jie Yu; Richard Platt; Tracy A Lieu
Journal:  Pediatrics       Date:  2004-03       Impact factor: 7.124

9.  Impact of type A influenza on children: a retrospective study.

Authors:  J P Mullooly; W H Barker
Journal:  Am J Public Health       Date:  1982-09       Impact factor: 9.308

  9 in total
  14 in total

1.  The burden of influenza-associated critical illness hospitalizations.

Authors:  Justin R Ortiz; Kathleen M Neuzil; David K Shay; Tessa C Rue; Moni B Neradilek; Hong Zhou; Christopher W Seymour; Laura G Hooper; Po-Yung Cheng; Christopher H Goss; Colin R Cooke
Journal:  Crit Care Med       Date:  2014-11       Impact factor: 7.598

2.  Association of Early Oseltamivir With Improved Outcomes in Hospitalized Children With Influenza, 2007-2020.

Authors:  Patrick S Walsh; David Schnadower; Yin Zhang; Sriram Ramgopal; Samir S Shah; Paria M Wilson
Journal:  JAMA Pediatr       Date:  2022-09-19       Impact factor: 26.796

3.  Signs of the 2009 influenza pandemic in the New York-Presbyterian Hospital electronic health records.

Authors:  Hossein Khiabanian; Antony B Holmes; Brendan J Kelly; Mrinalini Gururaj; George Hripcsak; Raul Rabadan
Journal:  PLoS One       Date:  2010-09-09       Impact factor: 3.240

4.  Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis.

Authors:  Tellen D Bennett; Mark Fluchel; Aimee O Hersh; Kristen N Hayward; Adam L Hersh; Thomas V Brogan; Rajendu Srivastava; Bryan L Stone; E Kent Korgenski; Michael B Mundorff; T Charles Casper; Susan L Bratton
Journal:  Arthritis Rheum       Date:  2012-12

5.  A National Study of the Impact of Rapid Influenza Testing on Clinical Care in the Emergency Department.

Authors:  Anne J Blaschke; Daniel J Shapiro; Andrew T Pavia; Carrie L Byington; Krow Ampofo; Chris Stockmann; Adam L Hersh
Journal:  J Pediatric Infect Dis Soc       Date:  2013-11-13       Impact factor: 3.164

6.  Burden of Influenza-Related Hospitalizations and Attributable Mortality in Pediatric Acute Lymphoblastic Leukemia.

Authors:  Grace E Lee; Brian T Fisher; Rui Xiao; Susan E Coffin; Kristen Feemster; Alix E Seif; Rochelle Bagatell; Yimei Li; Yuan-Shung V Huang; Richard Aplenc
Journal:  J Pediatric Infect Dis Soc       Date:  2014-07-22       Impact factor: 3.164

7.  Burden of influenza-related hospitalizations among children with sickle cell disease.

Authors:  David G Bundy; John J Strouse; James F Casella; Marlene R Miller
Journal:  Pediatrics       Date:  2010-01-25       Impact factor: 7.124

8.  Estimated paediatric mortality associated with influenza virus infections, United States, 2003-2010.

Authors:  K K Wong; P Cheng; I Foppa; S Jain; A M Fry; L Finelli
Journal:  Epidemiol Infect       Date:  2014-05-15       Impact factor: 4.434

9.  The cost of community-managed viral respiratory illnesses in a cohort of healthy preschool-aged children.

Authors:  Stephen B Lambert; Kelly M Allen; Robert C Carter; Terence M Nolan
Journal:  Respir Res       Date:  2008-01-24

10.  Evaluation of 3 electronic methods used to detect influenza diagnoses during 2009 pandemic.

Authors:  Sunita Mulpuru; Tiffany Smith; Nadine Lawrence; Kumanan Wilson; Alan J Forster
Journal:  Emerg Infect Dis       Date:  2013-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.